Skip to content

Limb fat gains lower when switching from AZT to abacavir or tenofovir, compared with d4T

HAART reduces liver damage in HIV / hepatitis C co-infected patients

Premature to say atazanavir not linked to fat loss, says lipodystrophy expert

Clostridium difficile most common cause of bacterial diarrhoea in HIV-positive patients

Neurological side-effects of efavirenz mild and transient, study claims

Less than half of deaths at London HIV clinic due to AIDS since 1998

Previous immune damage and response to HIV treatment associated with TB after starting antiretrovirals

HIV treatment reduces risk of TB in South Africa more than previously thought

Hospitalisations and deaths down in US, slight increase in number of admissions due to liver problems